LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $349,000 | -28.6% | 3,000 | 0.0% | 0.03% | +7.1% |
| Q4 2021 | $489,000 | +16.4% | 3,000 | 0.0% | 0.03% | +33.3% |
| Q3 2021 | $420,000 | +3.7% | 3,000 | 0.0% | 0.02% | -12.5% |
| Q2 2021 | $405,000 | -9.4% | 3,000 | 0.0% | 0.02% | -31.4% |
| Q1 2021 | $447,000 | +51.0% | 3,000 | 0.0% | 0.04% | +84.2% |
| Q4 2020 | $296,000 | +3.1% | 3,000 | 0.0% | 0.02% | -24.0% |
| Q3 2020 | $287,000 | -15.3% | 3,000 | 0.0% | 0.02% | -24.2% |
| Q2 2020 | $339,000 | +58.4% | 3,000 | 0.0% | 0.03% | +57.1% |
| Q1 2020 | $214,000 | -33.3% | 3,000 | 0.0% | 0.02% | -22.2% |
| Q4 2019 | $321,000 | +8.1% | 3,000 | 0.0% | 0.03% | -18.2% |
| Q3 2019 | $297,000 | -13.2% | 3,000 | 0.0% | 0.03% | +43.5% |
| Q2 2019 | $342,000 | -7.8% | 3,000 | 0.0% | 0.02% | -4.2% |
| Q1 2019 | $371,000 | -9.7% | 3,000 | 0.0% | 0.02% | -4.0% |
| Q4 2018 | $411,000 | -50.0% | 3,000 | 0.0% | 0.02% | -35.9% |
| Q3 2018 | $822,000 | – | 3,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |